Suppr超能文献

在新冠疫情期间改善急性缺血性卒中的门到再灌注时间:来自巴西一家公立综合卒中中心的经验

Improving door-to-reperfusion time in acute ischemic stroke during the COVID-19 pandemic: experience from a public comprehensive stroke center in Brazil.

作者信息

Klu Marcelo, de Souza Ana Claudia, Carbonera Leonardo Augusto, Secchi Thais Leite, Pille Arthur, Rodrigues Marcio, Brondani Rosane, de Almeida Andrea Garcia, Dal Pizzol Angélica, Camelo Daniel Monte Freire, Mantovani Gabriel Paulo, Oldoni Carolina, Tessari Marcelo Somma, Nasi Luiz Antonio, Martins Sheila Cristina Ouriques

机构信息

Emergency Department, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Neurology Department, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

出版信息

Front Neurol. 2023 Jul 10;14:1155931. doi: 10.3389/fneur.2023.1155931. eCollection 2023.

Abstract

BACKGROUND

The global COVID-19 pandemic has had a devastating effect on global health, resulting in a strain on healthcare services worldwide. The faster a patient with acute ischemic stroke (AIS) receives reperfusion treatment, the greater the odds of a good functional outcome. To maintain the time-dependent processes in acute stroke care, strategies to reorganize infrastructure and optimize human and medical resources were needed.

METHODS

Data from AIS patients who received thrombolytic therapy were prospectively assessed in the emergency department (ED) of Hospital de Clínicas de Porto Alegre from 2019 to 2021. Treatment times for each stage were measured, and the reasons for a delay in receiving thrombolytic therapy were evaluated.

RESULTS

A total of 256 patients received thrombolytic therapy during this period. Patients who arrived by the emergency medical service (EMS) had a lower median door-to-needle time (DNT). In the multivariable analysis, the independent predictors of DNT >60 min were previous atrial fibrillation (OR 7) and receiving thrombolysis in the ED (OR 9). The majority of patients had more than one reason for treatment delay. The main reasons were as follows: delay in starting the CT scan, delay in the decision-making process after the CT scan, and delay in reducing blood pressure. Several actions were implemented during the study period. The most important factor that contributed to a decrease in DNT was starting the bolus and continuous infusion of tPA on the CT scan table (decreased the median DNT from 74 to 52, DNT ≤ 60 min in 67% of patients treated at radiology service vs. 24% of patients treated in the ED). The DNT decreased from 78 min to 66 min in 2020 and 57 min in 2021 ( = 0.01).

CONCLUSION

Acute stroke care continued to be a priority despite the COVID-19 pandemic. The implementation of a thrombolytic bolus and the start of continuous infusion on the CT scan table was the main factor that contributed to the reduction of DNT. Continuous monitoring of service times is essential for improving the quality of the stroke center and achieving better functional outcomes for patients.

摘要

背景

全球新冠疫情对全球健康造成了毁灭性影响,导致全球医疗服务紧张。急性缺血性卒中(AIS)患者接受再灌注治疗的速度越快,获得良好功能预后的几率就越大。为维持急性卒中治疗中的时间依赖性流程,需要采取重组基础设施以及优化人力和医疗资源的策略。

方法

对2019年至2021年在阿雷格里港临床医院急诊科接受溶栓治疗的AIS患者数据进行前瞻性评估。测量每个阶段的治疗时间,并评估接受溶栓治疗延迟的原因。

结果

在此期间共有256例患者接受了溶栓治疗。通过紧急医疗服务(EMS)送达的患者中位门到针时间(DNT)较低。在多变量分析中,DNT>60分钟的独立预测因素是既往心房颤动(比值比[OR]为7)和在急诊科接受溶栓治疗(OR为9)。大多数患者存在不止一个治疗延迟的原因。主要原因如下:CT扫描启动延迟、CT扫描后决策过程延迟以及血压降低延迟。在研究期间实施了多项措施。导致DNT降低的最重要因素是在CT扫描台上开始推注和持续输注组织型纤溶酶原激活剂(tPA)(将中位DNT从74分钟降至52分钟,在放射科接受治疗的患者中67%的患者DNT≤60分钟,而在急诊科接受治疗的患者中这一比例为24%)。DNT在2020年从78分钟降至66分钟,在2021年降至57分钟(P = 0.01)。

结论

尽管有新冠疫情,急性卒中治疗仍是优先事项。在CT扫描台上实施溶栓推注并开始持续输注是导致DNT降低的主要因素。持续监测服务时间对于提高卒中中心质量和为患者实现更好的功能预后至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a2b/10365273/d76e696761f0/fneur-14-1155931-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验